Safety, Immunogenicity and Lot-to-Lot Consistency of Sabin-Strain Inactivated Poliovirus Vaccine in 2-Month-Old Infants: A Double-Blind, Randomized Phase III Trial

Background: The Sabin-strain-based inactivated poliovirus vaccine (sIPV) plays an important role in poliomyelitis eradication in developing countries. As part of the phase III clinical development program, this study aimed to evaluate the safety, immunogenicity and lot-to-lot consistency of the sIPV...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yan, Ying, Zhifang, Zou, Yanxiang, Zhu, Taotao, Qian, Dinggu, Han, Weixiao, Jiang, Ya, Jiang, Zhiwei, Li, Xingyan, Wang, Jianfeng, Lei, Jin, Xu, Li, Jiang, Deyu, Li, Changgui, Liu, Xiaoqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879689/
https://www.ncbi.nlm.nih.gov/pubmed/35214712
http://dx.doi.org/10.3390/vaccines10020254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879689/
https://www.ncbi.nlm.nih.gov/pubmed/35214712
http://dx.doi.org/10.3390/vaccines10020254

Ejemplares similares